A Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to B-cell Lymphoma
Related studies linked through entity extraction aliases.
CAR T Cells for Refractory B Cell Malignancy
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Assess the Pharmacokinetics and Safety of Recombinant Human Murine Chimeric Anti CD20 Monoclonal Antibody Injection (IBI301) Compared to Rituximab Injection in CD20 Positive B Cell Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
BI-1206 and an Anti-CD20 Antibody in Patients With CD32b Positive B-cell Lymphoma or Leukaemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP
- Status
- COMPLETED
- Phase
- PHASE1
Allo HSCT Using RIC for Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
An Observational Study on Evaluating the Efficacy and Safety of Preemptive Antiviral Therapy With Tenofovir in HBsAg-positive Patients With Diffuse Large B-cell Lymphoma Receiving Rituximab-CHOP Chemotherapy (SPEED Study)
- Status
- UNKNOWN
- Phase
- N/A
Detection and Characterization of Residual Masses in Lymphomas
- Status
- COMPLETED
- Phase
- N/A
Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bruton's Tyrosine Kinase (BTK) Inhibition in B-cell Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1
Study of Ibrutinib in Combination With Rituximab in Previously Untreated Subjects With Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
- Status
- COMPLETED
- Phase
- N/A
Study of Standard-Dose Rituximab, Ifosfamide, Carboplatin and Etoposide
- Status
- TERMINATED
- Phase
- PHASE1
Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma)
- Status
- COMPLETED
- Phase
- PHASE1